Literature DB >> 23233734

Enriching the molecular definition of the airway "field of cancerization:" establishing new paradigms for the patient at risk for lung cancer.

Brigitte N Gomperts1, Tonya C Walser, Avrum Spira, Steven M Dubinett.   

Abstract

The "field of cancerization" refers to histologically normal-appearing tissue adjacent to neoplastic tissue that displays molecular abnormalities, some of which are the same as those of the tumor. Improving our understanding of these molecular events is likely to increase our understanding of carcinogenesis. Kadara and colleagues attempt to characterize the molecular events occurring temporally and spatially within the field of cancerization of patients with early-stage non-small cell lung cancer (NSCLC) following definitive surgery. They followed patients with bronchoscopies annually after tumor resection and extracted RNA from the serial brushings from different endobronchial sites. They then conducted microarray analysis to identify gene expression differences over time and in different sites in the airway. Candidate genes were found that may have biologic relevance to the field of cancerization. For example, expression of phosphorylated AKT and ERK1/2 was found to increase in the airway epithelium with time. Although there are limitations in the study design, this investigation demonstrates the utility of identifying molecular changes in histologically normal airway epithelium in lung cancer. In addition to increasing our understanding of lung cancer biology, studying the field of cancerization has the potential to identify biomarkers from samples obtained in a minimally invasive manner. ©2013 AACR.

Entities:  

Mesh:

Year:  2012        PMID: 23233734      PMCID: PMC3717378          DOI: 10.1158/1940-6207.CAPR-12-0470

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  21 in total

1.  Airway PI3K pathway activation is an early and reversible event in lung cancer development.

Authors:  Adam M Gustafson; Raffaella Soldi; Christina Anderlind; Mary Beth Scholand; Jun Qian; Xiaohui Zhang; Kendal Cooper; Darren Walker; Annette McWilliams; Gang Liu; Eva Szabo; Jerome Brody; Pierre P Massion; Marc E Lenburg; Stephen Lam; Andrea H Bild; Avrum Spira
Journal:  Sci Transl Med       Date:  2010-04-07       Impact factor: 17.956

2.  Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers.

Authors:  Yi-Chia Lee; Hsiu-Po Wang; Cheng-Ping Wang; Jenq-Yuh Ko; Jang-Ming Lee; Han-Mo Chiu; Jaw-Town Lin; Satoshi Yamashita; Daiji Oka; Naoko Watanabe; Yasunori Matsuda; Toshikazu Ushijima; Ming-Shiang Wu
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-27

3.  Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.

Authors:  W A Franklin; A F Gazdar; J Haney; I I Wistuba; F G La Rosa; T Kennedy; D M Ritchey; Y E Miller
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 4.  Evolving concepts in lung carcinogenesis.

Authors:  Brigitte N Gomperts; Avrum Spira; Pierre P Massion; Tonya C Walser; Ignacio I Wistuba; John D Minna; Steven M Dubinett
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

5.  EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.

Authors:  Ximing Tang; Hisayuki Shigematsu; B Nebiyou Bekele; Jack A Roth; John D Minna; Waun Ki Hong; Adi F Gazdar; Ignacio I Wistuba
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

Review 6.  Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancer.

Authors:  Ashley G Rivenbark; William B Coleman
Journal:  Exp Mol Pathol       Date:  2012-11-06       Impact factor: 3.362

Review 7.  Oral field cancerization: current evidence and future perspectives.

Authors:  Punnya V Angadi; J K Savitha; Sanjay S Rao; Y Sivaranjini
Journal:  Oral Maxillofac Surg       Date:  2012-02-22

8.  A prediction model for lung cancer diagnosis that integrates genomic and clinical features.

Authors:  Jennifer Beane; Paola Sebastiani; Theodore H Whitfield; Katrina Steiling; Yves-Martine Dumas; Marc E Lenburg; Avrum Spira
Journal:  Cancer Prev Res (Phila)       Date:  2008-03-31

9.  Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers.

Authors:  M A Nelson; J Wymer; N Clements
Journal:  Cancer Lett       Date:  1996-05-15       Impact factor: 8.679

10.  Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium.

Authors:  Sriram Sridhar; Frank Schembri; Julie Zeskind; Vishal Shah; Adam M Gustafson; Katrina Steiling; Gang Liu; Yves-Martine Dumas; Xiaohui Zhang; Jerome S Brody; Marc E Lenburg; Avrum Spira
Journal:  BMC Genomics       Date:  2008-05-30       Impact factor: 3.969

View more
  12 in total

Review 1.  Update in lung cancer and mesothelioma 2012.

Authors:  Charles A Powell; Balazs Halmos; Serge P Nana-Sinkam
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

2.  Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.

Authors:  Guoying Yu; Jose D Herazo-Maya; Tomoko Nukui; Marjorie Romkes; Anil Parwani; Brenda M Juan-Guardela; Jennifer Robertson; Jack Gauldie; Jill M Siegfried; Naftali Kaminski; Daniel J Kass
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

Review 3.  Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.

Authors:  Brielle A Parris; Hannah E O'Farrell; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 4.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

5.  Decreased Interferon Alpha/Beta Signature Associated with Human Lung Tumorigenesis.

Authors:  Run Tong; Lin Feng; Lei Zhang; Jianzhi Zhang; Yousheng Mao; Kaitai Zhang; Yanning Gao; Guiqi Wang; Shujun Cheng
Journal:  J Interferon Cytokine Res       Date:  2015-08-26       Impact factor: 2.607

6.  APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylation.

Authors:  Daniela Furlan; Nora Sahnane; Barbara Bernasconi; Milo Frattini; Maria Grazia Tibiletti; Francesca Molinari; Alessandro Marando; Lizhi Zhang; Alessandro Vanoli; Selenia Casnedi; Volkan Adsay; Kenji Notohara; Luca Albarello; Sofia Asioli; Fausto Sessa; Carlo Capella; Stefano La Rosa
Journal:  Virchows Arch       Date:  2014-03-04       Impact factor: 4.064

Review 7.  Acinar Cell Carcinoma of the Pancreas: Overview of Clinicopathologic Features and Insights into the Molecular Pathology.

Authors:  Stefano La Rosa; Fausto Sessa; Carlo Capella
Journal:  Front Med (Lausanne)       Date:  2015-06-15

8.  Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.

Authors:  Jun-Chieh J Tsay; Zhiguo Li; Ting-An Yie; Feng Wu; Leopoldo Segal; Alissa K Greenberg; Eric Leibert; Michael D Weiden; Harvey Pass; John Munger; Alexander Statnikov; Kam-Meng Tchou-Wong; William N Rom
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

9.  LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.

Authors:  Yuho Maki; Junya Fujimoto; Wenhua Lang; Li Xu; Carmen Behrens; Ignacio I Wistuba; Humam Kadara
Journal:  Sci Rep       Date:  2015-09-07       Impact factor: 4.379

10.  LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells.

Authors:  Q Wei; Z-H Chen; L Wang; T Zhang; L Duan; C Behrens; I I Wistuba; J D Minna; B Gao; J-H Luo; Z P Liu
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.